ClinicalTrials.gov
ClinicalTrials.gov Menu

Ruxolitinib and Lenalidomide for Patients With Myelofibrosis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01375140
Recruitment Status : Completed
First Posted : June 17, 2011
Last Update Posted : October 19, 2018
Sponsor:
Collaborator:
Incyte Corporation
Information provided by (Responsible Party):
M.D. Anderson Cancer Center

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : September 5, 2018
  Actual Study Completion Date : September 5, 2018